Endometrial cancer, as a component of LS tumors, was the third most frequent, with the great majority found in mutation carriers (18 out 19, 95%) (5 in MLH1, 8 in MSH2 and 5 in MSH6 carriers). Here, MSH6 is linked to endometrial cancer.